Clinical Trial Update: Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome [Phase 3]

View source ↗

Summary

A phase 3 clinical trial evaluating the use of angiotensin converting enzyme inhibitors in Marfan syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marfan Syndrome

Drugs mentioned

• ACE inhibitors

Snippet

Sponsor: Bayside Health | Conditions: Marfan Syndrome | Phase 3 | Status: COMPLETED